Adrafinil occupies an unusual place in the world of wakefulness compounds. It was the first eugeroic ever brought to market, it is the direct chemical ancestor of modafinil, and yet it was discontinued by its own manufacturer years ago. Today it survives mainly as an unregulated nootropic in countries where modafinil requires a prescription, prized by some for its accessibility and criticized by others for the extra burden it places on the liver.
To understand adrafinil properly, you need to understand one concept: it is a prodrug. On its own, adrafinil does very little. Its effects come entirely from what your liver turns it into — modafinil. That single fact explains its slower onset, its higher doses, its side-effect profile, and why it was eventually abandoned by the pharmaceutical industry. This article walks through the whole story, from discovery to metabolism to practical guidance, for anyone curious about adrafinil and how it compares with its better-known descendant.
A Brief History: From France to the Nootropic Forums
Adrafinil was discovered in the 1970s by researchers at the French pharmaceutical company Laboratoires Lafon, who were exploring compounds that promoted wakefulness without the stimulant properties of amphetamines. Sold under the brand name Olmifon, it was marketed in France from the mid-1980s primarily for elderly patients with vigilance problems and, more broadly, for excessive daytime sleepiness.
While studying adrafinil, the same researchers noticed that its main active metabolite was even more potent and better tolerated. That metabolite was modafinil, which entered the market in France in the early 1990s and later gained approval in the United States as Provigil in 1998. Modafinil quickly overtook its parent compound. Cephalon, the US company that acquired Lafon and the rights to both drugs, eventually discontinued Olmifon in 2011, judging that modafinil had made adrafinil obsolete.
Since then, adrafinil has lived a second life in the nootropic community. Because it was never scheduled as a controlled substance in the US and many other countries, it is sold as a research chemical or dietary-style supplement in places where modafinil itself requires a prescription. That legal gap, rather than any pharmacological advantage, is the main reason people still use it.
What a Prodrug Is and Why It Matters
A prodrug is a compound that is inactive, or only weakly active, in the form you take it, and that the body converts into an active drug through metabolism. Prodrugs exist for various reasons: sometimes to improve absorption, sometimes to extend duration, sometimes because the active form was discovered later.
In adrafinil’s case, the chemistry is simple. Adrafinil is structurally modafinil with an extra hydroxyl group attached to the amide nitrogen — technically it is a hydroxylamide rather than an amide. When adrafinil reaches the liver, enzymes strip that hydroxyl group away, leaving modafinil. From that point, everything that happens in the brain is modafinil’s doing.
This has several direct consequences.
Slower Onset
Modafinil taken directly reaches meaningful blood concentrations within about an hour and full effect within two. Adrafinil has to be absorbed, transported to the liver, and converted first. Most users report that adrafinil takes 60–120 minutes longer to reach a comparable effect — often two to three hours in total.
Lower Effective Potency
Not all of the adrafinil you swallow becomes modafinil. A meaningful fraction is metabolized through other routes into inactive compounds like modafinilic acid. As a result, a milligram of adrafinil delivers noticeably less than a milligram of modafinil. Historically, prescribed adrafinil doses were 300–600 mg per day, compared with 100–200 mg for modafinil. A common rule of thumb in the nootropic community is that roughly 300 mg of adrafinil approximates 100 mg of modafinil, though individual conversion varies.
Liver Workload
Here is the crux of adrafinil’s problem. The conversion happens in the liver, and chronic use has been associated with elevated liver enzymes. Modafinil is also metabolized by the liver, but the additional metabolic step required for adrafinil, along with the higher doses needed, appears to add burden. This concern was documented in the original French prescribing information and has been reinforced by case reports and community experience.
How the Active Metabolite Works in the Brain
Once adrafinil has become modafinil, the mechanism is identical to taking modafinil directly. Modafinil is a eugeroic, a wakefulness-promoting agent that acts primarily by inhibiting the dopamine transporter. This raises dopamine levels modestly in regions associated with attention and motivation. Downstream, it increases activity in the orexin and histamine systems, which are central to sustaining arousal.
Unlike amphetamines, modafinil does not force dopamine release, does not produce significant euphoria, and has low abuse potential. It is classified as Schedule IV in the United States. Its half-life is roughly 12–15 hours, which gives a long, steady plateau of alertness from a single morning dose.
Adrafinil inherits all of these properties, delayed by the conversion step. The practical effect is a slightly later start and a slightly later finish, which is one reason evening insomnia is a frequent complaint among adrafinil users who dose in the late morning.
Adrafinil vs Modafinil at a Glance
| Feature | Adrafinil | Modafinil |
| Status | Prodrug; converted in liver | Active drug |
| Typical historical dose | 300–600 mg | 100–200 mg |
| Onset | 2–3 hours | 1–2 hours |
| Effective duration | Similar once converted, shifted later | 10–14 hours |
| Liver enzyme concerns | Documented with chronic use | Low at standard doses |
| Manufacturer status | Discontinued (Olmifon, 2011) | Widely available, generic |
| US legal status | Unscheduled | Schedule IV, prescription |
| Approved medical uses today | None current | Narcolepsy, OSA sleepiness, shift work disorder |
The table makes the trade-off plain. Adrafinil’s only real advantage is legal accessibility in some jurisdictions. On every pharmacological dimension — onset, potency, predictability, liver safety — modafinil is the better compound. That is exactly why its manufacturer stopped making adrafinil.
Practical Considerations for Anyone Using Adrafinil
Despite the drawbacks, adrafinil is still used. If you are among those who use it, the following practices reflect what is known about the compound.
Dose Conservatively
Because conversion efficiency varies between individuals, start low. Many users begin at 150–300 mg and only increase if the effect is insufficient. Exceeding 600 mg offers little additional benefit and increases liver load.
Take It Early
Allow for the delayed onset. A dose at 7 a.m. may not fully kick in until 9 or 10, and with modafinil’s long half-life the effect will persist into the evening. Dosing after mid-morning invites insomnia.
Do Not Use It Daily for Extended Periods
This is the most important rule. The liver enzyme concern is specifically tied to chronic, regular use. Occasional or intermittent use — a few times a week at most, with regular breaks — is how most experienced users approach it. Some people limit themselves to short cycles of a few weeks followed by a break of equal or greater length.
Monitor Liver Function
Anyone using adrafinil more than occasionally should consider periodic liver function tests. Elevated ALT or AST is an early warning that should prompt discontinuation.
Avoid Alcohol and Other Hepatotoxic Substances
Combining adrafinil with alcohol, acetaminophen at high doses, or other compounds that stress the liver compounds the risk.
Be Cautious With Powder
Adrafinil is often sold as a powder, which requires accurate milligram scales to dose. It is also somewhat unstable; it degrades with heat, light, and moisture, and old powder may have lost potency or developed impurities.
A brief responsible-use note: adrafinil is not an approved medication anywhere at present, and its legal status as a supplement varies by country — it is, for instance, banned by the World Anti-Doping Agency for athletes in competition. Talk to a doctor before using it, particularly if you have any history of liver problems, and remember that it promotes wakefulness without substituting for sleep.
Side Effects Specific to Adrafinil
Most of adrafinil’s side effects are the same as modafinil’s: headache, nausea, dry mouth, reduced appetite, anxiety at higher doses, and insomnia when taken too late. Two are more specific to adrafinil.
Elevated liver enzymes. Discussed above; the defining concern with chronic use.
Orofacial dyskinesia. A small number of case reports describe involuntary facial movements in elderly patients on long-term adrafinil. This appears rare but is a reason for caution in older users and for anyone noticing unusual movements.
Some users also report that adrafinil feels “rougher” than modafinil, with more stomach discomfort and a less clean onset. Whether this reflects the conversion process, the higher doses, or the variable quality of unregulated products is unclear.
Why Adrafinil Persists Despite Its Flaws
Given everything above, the obvious question is why anyone uses adrafinil at all. The answer is almost entirely about access.
In the US, UK, Canada, Australia, and much of Europe, modafinil requires a prescription. Adrafinil is not a controlled substance in most of those places and is sold openly as a research compound. For someone without a prescription who wants a modafinil-like effect, adrafinil is the legal path of least resistance.
This is a pragmatic reason, not a pharmacological one. If you have legitimate access to modafinil — through a prescription or in a jurisdiction where it is available — there is no meaningful case for choosing adrafinil instead. You would be paying with liver risk and unpredictability to get a delayed, weaker version of the same active molecule.
FAQ
Is adrafinil the same as modafinil? No. Adrafinil is a prodrug that the liver converts into modafinil. The final active compound is the same, but adrafinil has slower onset, lower effective potency, and greater liver burden.
How much adrafinil equals 100 mg of modafinil? There is no exact conversion because metabolism varies, but roughly 300 mg of adrafinil is often compared with 100 mg of modafinil. Historical prescribed doses were 300–600 mg per day.
Is adrafinil bad for your liver? Chronic, regular use has been associated with elevated liver enzymes, and this concern appeared in the original prescribing information. Occasional use appears far less risky, but anyone using it regularly should monitor liver function.
Why was adrafinil discontinued? Cephalon discontinued Olmifon in 2011 because modafinil, its active metabolite, was more potent, faster, and better tolerated. There was no commercial or medical reason to keep the parent compound on the market.
Is adrafinil legal? It is unscheduled in the US and many other countries, where it is sold as a research chemical or supplement. Some jurisdictions restrict it, and it is banned in competitive sport by WADA. Check local regulations.
Final Thoughts
Adrafinil is best understood as modafinil with a detour. Everything useful about it comes from the modafinil your liver produces from it; everything problematic — the slow onset, the high doses, the liver enzyme concern — comes from the detour itself. That is why the company that discovered both compounds abandoned the older one once the newer one was available.
For people without access to modafinil, adrafinil remains a functional, if imperfect, alternative, best used sparingly, dosed early, and with an eye on liver health. For anyone who can obtain modafinil legitimately, the choice is clear. Whichever path you take, treat any wakefulness-promoting agent with respect for what it can do and honesty about what it cannot: it will keep you alert, but only sleep will keep you well.
For more topic guides and related resources, visit Modavance.
